Computerized counseling for folate knowledge and use: a randomized controlled trial
- PMID: 19000845
- PMCID: PMC2593421
- DOI: 10.1016/j.amepre.2008.06.034
Computerized counseling for folate knowledge and use: a randomized controlled trial
Abstract
Background: Periconception folate supplementation significantly reduces the risk of neural-tube defects, but few U.S. women start folate supplementation before pregnancy, and the amount of clinician time available to counsel patients about folate is limited. This study evaluated whether computer-assisted counseling and the provision of free folate tablets increases women's knowledge and use of folate supplements.
Design: Randomized controlled trial; follow-up began 6 months after enrollment and was completed on average 7 months after enrollment.
Setting/participants: A total of 446 women, aged 18-45 years, were recruited from two urgent care clinics in San Francisco from March to July 2005 (data collection was completed in 2006; data were analyzed in 2007).
Intervention: Participants received a 15-minute computerized educational session and 200 folate tablets.
Main outcome measures: The primary outcome was the knowledge that folate can prevent birth defects; secondary outcomes included the self-reported use of a folate supplement at follow-up.
Results: At follow-up, women in the intervention group were more likely to know that folate prevents birth defects (46% vs 27%, relative risk [RR]=1.72, 95% CI=1.32, 2.23); to know that folate is most important in early pregnancy (36% vs 17%, RR=2.11, 95% CI=1.50, 2.97); and to report the recent use of a folate supplement (32% vs 21%, RR=1.54, 95% CI=1.12, 2.13).
Conclusions: A one-time, brief, computerized counseling session about folate with the provision of free folate tablets increased the knowledge and use of folate supplements among women > or =6 months later.
Trial registration: NCT00177515.
Comment in
-
Elimination of folic acid-preventable neural tube defects.Am J Prev Med. 2008 Dec;35(6):606-7. doi: 10.1016/j.amepre.2008.09.017. Am J Prev Med. 2008. PMID: 19000851 No abstract available.
References
-
- CDC Use of dietary supplements containing folic acid among women of childbearing age—U.S., 2005. MMWR Morb Mortal Wkly Rep. 2005;54(38):955–8. - PubMed
-
- Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001;(3) CD001056. - PubMed
-
- Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the U.S., 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–6. - PubMed
-
- CDC Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep. 1992;41(RR14):1–7.
-
- Chacko MR, Anding R, Kozinetz CA, Grover JL, Smith PB. Neural tube defects: knowledge and preconceptional prevention practices in minority young women. Pediatrics. 2003;112(3 Pt 1):536–42. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
